BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

813 related articles for article (PubMed ID: 18282652)

  • 1. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
    Turner BJ; Talbot K
    Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
    Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
    Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amyotrophic lateral sclerosis: recent insights from transgenic animal models with SOD1 mutations].
    Aoki M
    Rinsho Shinkeigaku; 2004 Nov; 44(11):788-91. PubMed ID: 15651292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.
    Gurney ME; Cutting FB; Zhai P; Andrus PK; Hall ED
    Pathol Biol (Paris); 1996 Jan; 44(1):51-6. PubMed ID: 8734301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].
    Nakano R
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1546-8. PubMed ID: 8752459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of three mutations in the Cu,Zn-superoxide dismutase (Cu,Zn-SOD) gene with familial amyotrophic lateral sclerosis: transduction of human Cu,Zn-SOD into PC12 cells by HIV-1 TAT protein basic domain.
    Chou CM; Huang CJ; Shih CM; Chen YP; Liu TP; Chen CT
    Ann N Y Acad Sci; 2005 May; 1042():303-13. PubMed ID: 15965076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis.
    Andreassen OA; Ferrante RJ; Klivenyi P; Klein AM; Shinobu LA; Epstein CJ; Beal MF
    Ann Neurol; 2000 Apr; 47(4):447-55. PubMed ID: 10762155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice.
    Kieran D; Kalmar B; Dick JR; Riddoch-Contreras J; Burnstock G; Greensmith L
    Nat Med; 2004 Apr; 10(4):402-5. PubMed ID: 15034571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of superoxide dismutase elevates reactive species: comparison of nitration and oxidation of proteins in different brain regions of transgenic mice with amyotrophic lateral sclerosis.
    Liu D; Bao F; Wen J; Liu J
    Neuroscience; 2007 Apr; 146(1):255-64. PubMed ID: 17368952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
    Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
    J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the structure of the Golgi apparatus and the function of the secretory pathway by mutants G93A and G85R of Cu, Zn superoxide dismutase (SOD1) of familial amyotrophic lateral sclerosis.
    Stieber A; Gonatas JO; Moore JS; Bantly A; Yim HS; Yim MB; Gonatas NK
    J Neurol Sci; 2004 Apr; 219(1-2):45-53. PubMed ID: 15050437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of nuclear factor-kappaB activation increased glutamate excitotoxicity in a motoneuron-neuroblastoma hybrid cell line expressing mutant (G93A) Cu/Zn-superoxide dismutase.
    Pyo JS; Ko YS; Kim WH; Kim M; Lee KW; Nam SY; Chung HY; Cho SJ; Baik TK; Lee BL
    J Neurosci Res; 2010 Aug; 88(11):2494-503. PubMed ID: 20623531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extra axonal neurofilaments do not exacerbate disease caused by mutant Cu,Zn superoxide dismutase.
    Couillard-Després S; Meier J; Julien JP
    Neurobiol Dis; 2000 Aug; 7(4):462-70. PubMed ID: 10964615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis.
    Gomes C; Keller S; Altevogt P; Costa J
    Neurosci Lett; 2007 Nov; 428(1):43-6. PubMed ID: 17942226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice.
    Gonzalez de Aguilar JL; Dupuis L; Oudart H; Loeffler JP
    Biomed Pharmacother; 2005 May; 59(4):190-6. PubMed ID: 15862714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 expression by retrograde transport of adenoviral vectors with Cre-loxP recombination system in motor neurons of mutant SOD1 transgenic mice.
    Yamashita S; Mita S; Arima T; Maeda Y; Kimura E; Nishida Y; Murakami T; Okado H; Uchino M
    Gene Ther; 2001 Jul; 8(13):977-86. PubMed ID: 11438832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Animal models of amyotrophic lateral sclerosis].
    Yamanaka K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):934-7. PubMed ID: 18210840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis.
    Urushitani M; Ezzi SA; Julien JP
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2495-500. PubMed ID: 17277077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
    Morrison BM; Morrison JH; Gordon JW
    J Exp Zool; 1998 Sep-Oct 1; 282(1-2):32-47. PubMed ID: 9723164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice.
    Turner BJ; Rembach A; Spark R; Lopes EC; Cheema SS
    J Neurosci Res; 2003 Nov; 74(4):605-13. PubMed ID: 14598305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.